Implementation of Continuous Subcutaneous Insulin Infusion Therapy: An Overview

Abstract

Continuous subcutaneous insulin infusion (CSII) devices are designed to provide physiologic insulinemia. Not only do they offer increased life-style flexi bility, they also make it possible to achieve near-normal levels of glycemia. These devices are programmed to deliver a continuous "basal" infusion. Preprandial bolus doses of insulin are given to prevent postprandial hyperglycemia. Careful patient screening and selection are necessary to ensure a successful outcome. Patients must have the maturity, technical ability, motivation, and financial resources needed to utilize CSII therapy. Initiation of CSII can be accomplished in an outpatient or inpatient setting, but both require a comprehensive educational curriculum.